Shuttle Pharmaceuticals to acquire United Dogecoin, becomes public Dogecoin miner with $11M PIPE

Shuttle Pharmaceuticals Holdings, Inc.

Merger consideration: 8,000 Series B-1 preferred shares convertible into ~32.3M common shares at $1.24 per share.
Concurrent $11M PIPE via Series B-2 convertible preferred and warrants; conversion price $1.03 per share.
United Dogecoin plans 3,000 ElphaPex mining rigs; targets 43,200 GH/s (~1.5% of global Dogecoin hash rate).
Ryan Trasolini (United Dogecoin CEO) to become co-CEO of combined company; closing expected May 4, 2026.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.99

Shuttle Pharmaceuticals Holdings, Inc. entered into Agreement and Plan of Merger with United Dogecoin Inc. valued at Merger consideration consisting of Series B-1 convertible preferred stock and up to 118,038,551 pre- (effective 2026-04-30).

Action: entry
Agreement: merger
Counterparty: United Dogecoin Inc.
Value: Merger consideration consisting of Series B-1 convertible preferred stock and up to 118,038,551 pre-
Effective: 2026-04-30

Exact text from the filing

On April 30, 2026, Shuttle Pharmaceuticals Holdings, Inc., a Delaware corporation (“ Shuttle ” or “ Acquiror ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Shuttle Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Shuttle (“ Merger Sub ”) and United Dogecoin Inc., a Delaware corporation (the “ Company ”).

View on SEC.gov

114 material agreements filed in the last 30 days. Browse all material agreements →

Shuttle Pharmaceuticals Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-020830

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.